Northwestern University Nanomedicine Cancer Vaccine Breakthrough

Scientists at Northwestern University, led by Chad Mirkin and Jochen Lorch, have discovered that the physical arrangement of vaccine ingredients at the nanoscale dramatically influences their performance. This principle, termed 'structural nanomedicine,' focuses on optimizing the orientation and position of components within spherical nucleic acids (SNAs) to enhance immune responses. Their research, published in Science Advances, demonstrated that a subtle change in antigen presentation on SNAs significantly strengthened the immune system's ability to attack HPV-driven tumors in humanized animal models and patient samples. This approach led to reduced tumor growth, prolonged survival, and increased cancer-killing T cells, without adding new ingredients or increasing dosage. The findings suggest a paradigm shift from traditional 'blender approach' vaccine development, potentially speeding up the creation of more potent and cost-effective therapeutic cancer vaccines. The study was supported by the United States===National Cancer Institute, the Lefkofsky Family Foundation, and the Robert H. Lurie Comprehensive Cancer Center.